US Patent Issued to Regeneron Pharmaceuticals on July 21 for "DARIC interleukin receptors" (Washington Inventor)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,711, issued on July 21, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"DARIC interleukin receptors" was invented by Wai-Hang Leung (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides improved compositions for adoptive T cell therapies for treating, preventing, or ameliorating at least one symptom of a cancer, infectious disease, autoimmune disease, inflammatory disease, and immunodeficiency, or condition associated therewith."

The patent was filed on March 5, 2024, under Application No. 18/595,641.

*For further information, including images, charts and tables, please visit: http://patft.uspto...